JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 14, 2003; DOI: 10.1124/jpet.103.057109


0022-3565/04/3083-1138-1147$20.00
JPET 308:1138-1147, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.057109v1
308/3/1138    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hatanaka, T.
Right arrow Articles by Ganapathy, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hatanaka, T.
Right arrow Articles by Ganapathy, M. E.

ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION

Transport of Amino Acid-Based Prodrugs by the Na+- and Cl--Coupled Amino Acid Transporter ATB0,+ and Expression of the Transporter in Tissues Amenable for Drug Delivery

Takahiro Hatanaka, Masayuki Haramura, You-Jun Fei, Seiji Miyauchi, Christy C. Bridges, Preethi S. Ganapathy, Sylvia B. Smith, Vadivel Ganapathy, and Malliga E. Ganapathy

Departments of Medicine (M.E.G.), Biochemistry and Molecular Biology (T.H., Y.-J.F., S.M., C.C.B., V.G.), and Cellular Biology and Anatomy (S.B.S., P.S.G.), Medical College of Georgia, Augusta, Georgia; and Chugai Biopharmaceuticals, Inc., San Diego, California (M.H.)

We evaluated the potential of the Na+- and Cl--coupled amino acid transporter ATB0,+ as a delivery system for amino acid-based prodrugs. Immunofluorescence analysis indicated that ATB0,+ is expressed abundantly on the luminal surface of cells lining the lumen of the large intestine and the airways of the lung and in various ocular tissues, including the conjunctival epithelium, the tissues easily amenable for drug delivery. We screened a variety of {beta}-carboxyl derivatives of aspartate and {gamma}-carboxyl derivatives of glutamate as potential substrates for this transporter using heterologous expression systems. In mammalian cells expressing the cloned ATB0,+, several of the aspartate and glutamate derivatives inhibited glycine transport via ATB0,+. Direct evidence for ATB0,+-mediated transport of these derivatives was obtained in Xenopus laevis oocytes using electrophysiological methods. Exposure of oocytes, which express ATB0,+ heterologously, to aspartate {beta}-benzyl ester as a model derivative induced inward currents in a Na+- and Cl--dependent manner with a Na+/Cl-/aspartate {beta}-benzyl ester stoichiometry of 2:1:1. ATB0,+ transported not only the {beta}-carboxyl derivatives of aspartate and the {gamma}-carboxyl derivatives of glutamate but also valacyclovir, which is an {alpha}-carboxyl ester of acyclovir with valine. The transport of valacyclovir via ATB0,+ was demonstrable in both heterologous expression systems. This process was dependent on Na+ and Cl-. The ability of ATB0,+ to transport valacyclovir was comparable with that of the peptide transporter PEPT1. These findings suggest that ATB0,+ has significant potential as a delivery system for amino acid-based drugs and prodrugs.


Received for publication July 16, 2003
Accepted November 5, 2003.

Address correspondence to: Dr. Malliga E. Ganapathy, Department of Medicine, Medical College of Georgia, Augusta, GA 30912. E-mail: mganapat{at}mail.mcg.edu




This article has been cited by other articles:


Home page
J. Physiol.Home page
C. M. H. Anderson, V. Ganapathy, and D. T. Thwaites
Human solute carrier SLC6A14 is the {beta}-alanine carrier
J. Physiol., September 1, 2008; 586(17): 4061 - 4067.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
S. R. Srinivas, P. D. Prasad, N. S. Umapathy, V. Ganapathy, and P. S. Shekhawat
Transport of butyryl-L-carnitine, a potential prodrug, via the carnitine transporter OCTN2 and the amino acid transporter ATB0,+
Am J Physiol Gastrointest Liver Physiol, November 1, 2007; 293(5): G1046 - G1053.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
D. T. Thwaites and C. M. H. Anderson
H+-coupled nutrient, micronutrient and drug transporters in the mammalian small intestine
Exp Physiol, July 1, 2007; 92(4): 603 - 619.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Hatanaka, Y. Hatanaka, and M. Setou
Regulation of Amino Acid Transporter ATA2 by Ubiquitin Ligase Nedd4-2
J. Biol. Chem., November 24, 2006; 281(47): 35922 - 35930.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. C. Bridges and R. K. Zalups
System B0,+ and the Transport of Thiol-S-Conjugates of Methylmercury
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 948 - 956.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
L. J. Van Winkle, J. K. Tesch, A. Shah, and A. L. Campione
System B0,+ amino acid transport regulates the penetration stage of blastocyst implantation with possible long-term developmental consequences through adulthood
Hum. Reprod. Update, March 1, 2006; 12(2): 145 - 157.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. K. Bhardwaj, D. Herrera-Ruiz, P. J. Sinko, O. S. Gudmundsson, and G. Knipp
Delineation of Human Peptide Transporter 1 (hPepT1)-Mediated Uptake and Transport of Substrates with Varying Transporter Affinities Utilizing Stably Transfected hPepT1/Madin-Darby Canine Kidney Clones and Caco-2 Cells
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1093 - 1100.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
P. L. Lorenzi, C. P. Landowski, X. Song, K. Z. Borysko, J. M. Breitenbach, J. S. Kim, J. M. Hilfinger, L. B. Townsend, J. C. Drach, and G. L. Amidon
Amino Acid Ester Prodrugs of 2-Bromo-5,6-dichloro-1-({beta}-D-ribofuranosyl)benzimidazole Enhance Metabolic Stability in Vitro and in Vivo
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 883 - 890.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics.